Stereotaxis Return on Assets:
-25.57% for Dec. 31, 2012Stereotaxis Historical Return on Assets Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | -25.57% |
| Sept. 30, 2012 | -28.14% |
| June 30, 2012 | -39.58% |
| March 31, 2012 | -63.32% |
| Dec. 31, 2011 | -63.45% |
| Sept. 30, 2011 | -55.79% |
| June 30, 2011 | -49.06% |
| March 31, 2011 | -38.31% |
| Dec. 31, 2010 | -36.86% |
| Sept. 30, 2010 | -49.28% |
| June 30, 2010 | -51.40% |
| March 31, 2010 | -58.25% |
| Dec. 31, 2009 | -54.30% |
| Sept. 30, 2009 | -56.07% |
| June 30, 2009 | -62.14% |
| March 31, 2009 | -70.97% |
| Dec. 31, 2008 | -80.04% |
| Sept. 30, 2008 | -87.84% |
| June 30, 2008 | -84.60% |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
About Return on Assets
Return on Assets (ROA) shows the rate of return (after tax) being earned on all of the firm's assets regardless of financing structure (debt vs. equity). It is a measure of how efficiently the company is using all stakeholders' assets to earn returns.
Because ROA can differ significantly across firms, ROA is often used to compare a company over time or against companies that have similar financing structures.
Learn More
STXS Return on Assets Benchmarks
| Companies | |
|---|---|
| Boston Scientific | -25.25% |
| Edwards Lifesciences Corporation | 17.28% |
| Hansen Medical | -36.75% |
STXS Return on Assets Rankings
| Overall |
45th percentile 4339 of 8002 |
| Sector |
49th percentile 344 of 684 in Healthcare |
| Industry |
32nd percentile 50 of 74 in Medical Instruments & Supplies |
STXS Return on Assets Range, Past 5 Years
| Minimum | -87.84% | Sep 2008 |
| Maximum | -25.57% | Dec 2012 |
| Average | -55.52% |
